Celon Pharma S.A. (FRA:8RP)
4.765
-0.050 (-1.04%)
Last updated: Jan 26, 2026, 8:10 AM CET
Celon Pharma Revenue
Celon Pharma had revenue of 71.13M PLN in the quarter ending September 30, 2025, with 39.34% growth. This brings the company's revenue in the last twelve months to 225.60M, up 7.29% year-over-year. In the year 2024, Celon Pharma had annual revenue of 205.55M, down -4.25%.
Revenue (ttm)
225.60M PLN
Revenue Growth
+7.29%
P/S Ratio
5.27
Revenue / Employee
398.58K PLN
Employees
566
Market Cap
278.88M EUR
Revenue Chart
* This company reports financials in PLN.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 205.55M | -9.12M | -4.25% |
| Dec 31, 2023 | 214.66M | 20.78M | 10.72% |
| Dec 31, 2022 | 193.89M | -2.20M | -1.12% |
| Dec 31, 2021 | 196.09M | 38.64M | 24.54% |
| Dec 31, 2020 | 157.45M | 55.20M | 53.99% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Allane SE | 827.69M |
| SIMONA Aktiengesellschaft | 586.42M |
| centrotherm international AG | 288.81M |
| Eleving Group | 203.19M |
| ÜSTRA Hannoversche Verkehrsbetriebe Aktiengesellschaft | 171.37M |
| Novabase S.G.P.S. | 130.35M |
| EUWAX Aktiengesellschaft | 41.42M |
| STINAG Stuttgart Invest AG | 28.92M |